FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/13/2015 |
3. Issuer Name and Ticker or Trading Symbol
CABOT CORP [ CBT ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 18,904 | D | |
Common Stock | 1,000 | I | Held by wife |
Common Stock | 14,687 | I(1) | Through the Trustees for the Corporation's 401(k) Plan |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (Right to Buy) | (2) | 11/11/2020 | Common Stock | 15,909 | $34.64 | D | |
Employee Stock Option (Right to Buy) | (3) | 11/10/2021 | Common Stock | 19,553 | $32.95 | D | |
Employee Stock Option (Right to Buy) | (4) | 11/08/2022 | Common Stock | 19,662 | $35.25 | D | |
Employee Stock Option (Right to Buy) | (5) | 11/07/2023 | Common Stock | 13,344 | $47.62 | D | |
Employee Stock Option (Right to Buy) | (6) | 11/13/2024 | Common Stock | 15,625 | $46.03 | D | |
Phantom Stock | (7) | (7) | Common Stock | 9,492.8123 | (7) | D |
Explanation of Responses: |
1. Reflects retirement plan contributions by the Corporation. |
2. The option vested over a three year period as follows: 30% on November 12, 2011, 30% on November 12, 2012 and 40% on November 12, 2013. |
3. The option vested over a three year period as follows: 30% on November 11, 2012, 30% on November 11, 2013 and 40% on November 11, 2014. |
4. The option vests over a three year period as follows: 30% on November 9, 2013, 30% on November 9, 2014 and 40% on November 9, 2015. |
5. The option vests over a three year period as follows: 30% on November 8, 2014, 30% on November 8, 2015 and 40% on November 8, 2016. |
6. The option vests over a three year period as follows: 30% on November 14, 2015, 30% on November 14, 2016 and 40% on November 14, 2017. |
7. Each share of phantom stock is the economic equivalent of one share of Cabot Corporation common stock. The shares of phantom stock will be settled in shares of Cabot Corporation common stock upon termination of his employment with Cabot Corporation. |
Remarks: |
By: Kristine L. Ouimet, pursuant to a power of attorney from Friedrich von Gottberg | 03/16/2015 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |